Business News • PR NewsWire • Assurex Health Releases Enhanced Pharmacogenomic Test to Help Clinicians Select Medications for Depression, Anxiety and PTSD

Assurex Health Releases Enhanced Pharmacogenomic Test to Help Clinicians Select Medications for Depression, Anxiety and PTSD

Assurex Health Releases Enhanced Pharmacogenomic Test to Help Clinicians Select Medications for Depression, Anxiety and PTSD

MASON, Ohio, May 4, 2014 /PRNewswire/ -- Assurex Health today announced an enhancement of its GeneSight® Psychotropic test, providing clinicians with the most comprehensive genetic-based tool available to help them make individualized antidepressant and antipsychotic medication...

View More : http://www.prnewswire.com/news-releases/assurex-health-releases-enhanced-pharmacogenomic-test-to-help-clinicians-select-...

Releted News by prnewswire

United CEO Issues Statement on News of the Death of Jim Oberstar

System in Package Market (2D, 2.5D & 3D) Trends & Forecasts 2020

Global Brands, Innovators and Business Leaders Arrive at Ektron's User Conference to Explore the Power of Innovation

Assurex Health Releases Enhanced Pharmacogenomic Test to Help Clinicians Select Medications for Depression, Anxiety and PTSD

Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues

Exar Corporation Announces Fourth Quarter and Fiscal 2014 Results